Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Endeavour Silver Corp (EXK) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance

Endeavour Silver CorpTrade
Oruka Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Endeavour Silver Corp vs Oruka Therapeutics Inc. Common Stock — how do they compare? Endeavour Silver Corp trades at $8.05 (market cap $2.44B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B). The key difference: Oruka Therapeutics Inc. Common Stock is far larger — about 2.1× Endeavour Silver Corp's market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, Endeavour Silver Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Endeavour Silver Corp for 26 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.

EXKORKA
Market Cap
$2.44B$5.18B
Volume
5,983,279490,798
Sector
Basic MaterialsHealth
52-Week High
$14.12$113.08
52-Week Low
$7.07$26.19
Typical Hold Time
26 Days0 Days
Enterprise Value
$2.44B$4.31B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Endeavour Silver Corp

Endeavour Silver (EXK) trades at $8.24, down 3.51% on the day, amid a bearish technical signal with moving averages indicating selling pressure. The company reported a net loss of $119.1 million in 2025 but improved to a net profit of $66 million in 2026, driven by revenue growth from $468 million to $737 million. Recent news highlights operational progress at the Terronera mine and a temporary mechanical issue at Guanacevi, while analyst consensus remains strongly positive with 11 buy ratings.

The outlook for EXK hinges on successful execution of mine expansions and favorable silver prices, offering growth potential, but risks include operational disruptions, commodity price volatility, and high valuation multiples. Investors should weigh the strong analyst support against near-term profitability challenges and market sentiment.

Oruka Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EXK
99% Buy1% Sell
Avg holding period · 26 Days
ORKA
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Endeavour Silver Corp

Endeavour Silver is a mid-tier precious metals mining company. It operates silver-gold mines in Mexico and is focused on growing its production and reserves through exploration and the development of new mining projects.

Read more on EXK →

About Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.

Read more on ORKA →